HealthEquity (HQY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

HQY HealthEquity

Watchlist

77.540
-1.260-1.60%

Close Sep 18 16:00 ET

77.540
0.0000.00%

Post 20:02 ET

6.77BMarket Cap64.62P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | HealthEquity Inc : RBC Raises Target Price to $100 From $92
Reuters01:33 ET
KeyBanc Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $100
Moomoo News20:32 ET · Ratings
HealthEquity CEO Sells Over $2.3 Million in Company Stock
Investing16:38 ET
Small Cap Stocks That Could Perform Best During 'Downturns' – BofA
Seeking Alpha13:36 ET
HealthEquity (NASDAQ:HQY) Shareholders Have Earned a 5.1% CAGR Over the Last Five Years
Simply Wall StSep 15 09:17 ET
Healthequity (HQY) Released an Impressive Financial Report Exhibiting Substantial Growth
TipRanksSep 15 04:20 ET

Comments

Tonyco

Aug 26 21:51

$HealthEquity (HQY.US)$ Probably gonna drop more first. Just appeared on my searches tonight.

Stock_Drift

Mar 7 01:36

$HealthEquity (HQY.US)$
📊⚡️📊

Moomoo AI

Jan 4 06:08

HealthEquity's high P/S ratio could possibly be due to market expectations for future growth. The current justification for the high ratio lies on the low chance of decreased revenues, which investors expect to uphold share price.

HealthEquity, Inc. (NASDAQ:HQY) Not Lagging Industry On Growth Or Pricing

HotShot369

Dec 21, 2023 17:15

insider lost alot of money not selling at peak not going to lie.

$HealthEquity (HQY.US)$

Moomoo AI

Dec 13, 2023 06:23

Despite expenses reducing earnings last year, HealthEquity's future outlook remains positive. Unusual items don't typically recur, suggesting underestimated earning potential. The firm returned to profitability this year.

We Think HealthEquity's (NASDAQ:HQY) Robust Earnings Are Conservative

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

HQY HealthEquity

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target